Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jul 3;2(7):e197025.
doi: 10.1001/jamanetworkopen.2019.7025.

Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis

Su Lynn Yeoh  1 , John Eastwood  1   2   3   4   5 , Ian M Wright  6   7 , Rachael Morton  8 , Edward Melhuish  7   9   10 , Meredith Ward  1   10 , Ju Lee Oei  1   11
Affiliations
Meta-Analysis

Cognitive and Motor Outcomes of Children With Prenatal Opioid Exposure: A Systematic Review and Meta-analysis

Su Lynn Yeoh et al. JAMA Netw Open. .

Abstract

Importance: Prenatal opioid exposure (POE) is one of the fastest-growing global health problems, but its association with long-term neurologic and physical development remains unknown.

Objective: To assess the association between POE and cognitive and motor development in children from age 6 months to 18 years.

Data sources: Key search terms included prenatal opioid exposure, neonatal abstinence syndrome, and neurocognitive development. Studies were searched using PubMed and Embase, with no publication date restriction, through August 20, 2018.

Study selection: Only published cohort studies comparing the results of age-appropriate standardized cognitive and/or motor tests between children with any POE (aged 0-18 years) with drug-free controls were included. Data that were not convertible to means and SDs were excluded.

Data extraction and synthesis: This study was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines. Data were pooled using a random-effects model.

Main outcomes and measures: Standardized mean difference of cognitive and motor tests between POE and nonexposed children.

Results: Twenty-six peer-reviewed cohort studies were included. Cognitive outcomes were compared for a total of 1455 children with POE and 2982 nonexposed children across 3 age groups (mean [SE] age at cognitive testing was 13 [1.58] months for the toddler group; 4.5 [0.38] years for the preschool group; and 13 [2.36] years for the school-aged group). Motor outcomes were compared for 688 children with POE and 1500 nonexposed children up to age 6 years (mean [SD] age at motor testing, 2 [0.45] years). Standardized mean difference was lower in cognitive tests for children with POE at 0 to 2 years (d = -0.52; 95% CI, -0.74 to -0.31; P < .001) and 3 to 6 years (d = -0.38; 95% CI, -0.69 to -0.07; P < .001); the difference was not significant for those aged 7 to 18 years (d = -0.44; 95% CI, -1.16 to 0.28; P = .23). Motor scores were lower in children with POE (d = 0.49; 95% CI, 0.23-0.74; P < .001).

Conclusions and relevance: Prenatal opioid exposure appeared to be negatively associated with neurocognitive and physical development from age 6 months, and this association persisted until adolescence. The cause and association of this with POE or other factors (eg, withdrawal treatment) are uncertain but suggest that POE necessitates long-term support and intervention.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Figures

Figure 1.
Figure 1.. PRISMA Flow Diagram of Search
Figure 2.
Figure 2.. Cognitive Outcomes Among All Age Groups
IV indicates inverse variance method; POE, prenatal opioid exposure; and SMD, standardized mean difference.
Figure 3.
Figure 3.. Motor Results in Children Aged 0 to 6 Years
IV indicates inverse variance method; POE, prenatal opioid exposure; and SMD, standardized mean difference.
See this image and copyright information in PMC

References

    1. Patrick SW, Dudley J, Martin PR, et al. . Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135(5):-. doi:10.1542/peds.2014-3299 - DOI - PMC - PubMed
    1. Nørgaard M, Nielsson MS, Heide-Jørgensen U. Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study. Subst Abuse. 2015;9(suppl 2):5-11. - PMC - PubMed
    1. Patrick SW, Davis MM, Lehmann CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35(8):650-655. doi:10.1038/jp.2015.36 - DOI - PMC - PubMed
    1. Wu C-C, Hung C-J, Shen C-H, et al. . Prenatal buprenorphine exposure decreases neurogenesis in rats. Toxicol Lett. 2014;225(1):92-101. doi:10.1016/j.toxlet.2013.12.001 - DOI - PubMed
    1. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces apoptosis of human microglia and neurons. Neuropharmacology. 2002;42(6):829-836. doi:10.1016/S0028-3908(02)00030-8 - DOI - PubMed

MeSH terms

Substances